Midterm outcome of valve-sparing aortic root replacement in inherited connective tissue disorders

Ann Thorac Surg. 2011 Nov;92(5):1646-9; discussion 1649-50. doi: 10.1016/j.athoracsur.2011.06.090. Epub 2011 Oct 31.

Abstract

Background: This study determined the midterm outcome of valve-sparing aortic root replacement for patients with inherited connective tissue disorders.

Methods: From 1993 to 2008, 94 patients underwent valve-sparing aortic root replacement. Sixty patients (64%), average age 33 years (range, 15 to 61 years), had inherited connective tissue disorders: Marfan syndrome, 54 (92%); Loeys-Dietz syndrome, 5 (8%); and smooth muscle α-actin (ACTA2) mutation in 1. Median preoperative sinus diameter was 52 mm (range, 42 to 76 mm), and moderate/severe aortic regurgitation was present in 14 (23%). Seven (12%, 1993 to 1999) underwent remodeling procedures, and 53 had reimplantation procedures. Cusp repair was performed in 4. Median follow-up was 55 months (range, 1 to 149 months). There were 15 patients in the early term (1993 to 2000) and 45 in the late term (2001 to 2008).

Results: Four late deaths occurred (cardiac, 3; aortic, 1), with 10-year survival of 86%. Rates of freedom from aortic valve replacement at 5 and 10 years were 85% and 58% in remodeling and 96% and 58% in reimplantation. Risk factors for reoperations were postprocedure intraoperative aortic insufficiency greater than mild (p = 0.046), remodeling procedure (p = 0.016), and early term (p = 0.0002). One patient (2%) with none/trivial postprocedure aortic insufficiency required aortic valve replacement. Freedom from reoperation in patients with none/trivial postprocedure aortic insufficiency at 5 and 10 years was 100% and 67%.

Conclusions: Meticulous control of aortic insufficiency during operation would bring favorable midterm durability in valve-sparing aortic root replacement using a reimplantation technique, even in patients with inherited connective tissue disorders.

MeSH terms

  • Actins / genetics
  • Adolescent
  • Adult
  • Aortic Valve / surgery*
  • Heart Valve Diseases / etiology
  • Heart Valve Diseases / surgery*
  • Humans
  • Loeys-Dietz Syndrome / complications
  • Marfan Syndrome / complications
  • Middle Aged
  • Mutation
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • ACTA2 protein, human
  • Actins